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with consideration of infratentorial circulation 
value for diagnosing brain death
Antoine J. Marchand1*, Philippe Seguin2,3,4, Yannick Malledant2,3,4, Marion Taleb2, Hélène Raoult1 
and Jean Yves Gauvrit1,3
Abstract 
Background: Computed tomography angiography (CTA) is largely performed in European countries as an ancil-
lary test for diagnosing brain death. However, CTA suffers from a lack of sensitivity, especially in patients who have 
previously undergone decompressive craniectomy. The aim of this study was to assess the performance of a revised 
four-point venous CTA score, including non-opacification of the infratentorial venous circulation, for diagnosing brain 
death.
Methods: A preliminary study of 43 control patients with normal CTAs confirmed that the infratentorial superior pet-
rosal vein (SPV) was consistently visible. Therefore, 76 patients (including ten with decompressive craniectomy) who 
were investigated with 83 CTAs to confirm clinical brain death were consecutively enrolled between July 2011 and 
July 2013 at a university centre. The image analysis consisted of recording non-opacification of the cortical segment 
of the middle cerebral artery and internal cerebral vein (ICV), which were used as the reference CTA score, as well as 
non-opacification of the SPV. The diagnostic performance of the revised four-point venous CTA score based on the 
non-opacification of both the ICV and SPV was assessed and compared with that of the reference CTA score.
Results: The revised four-point venous CTA score showed a sensitivity of 95 % for confirming clinical brain death 
versus a sensitivity of 88 % with the reference CTA score. Non-opacification of the SPV was observed in 95 % of the 
patients. In the decompressive craniectomy group, the revised four-point CTA score showed a sensitivity of 100 % 
compared with a sensitivity of 80 % using the reference CTA score.
Conclusion: Compared with the reference CTA score, the revised four-point venous CTA score based on ICV and SPV 
non-opacification showed superior diagnostic performance for confirming brain death, including for patients with 
decompressive craniectomy.
Keywords: Brain death diagnosis, Computed tomography angiography, Confirmatory test,  
Revised four-point venous score
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Background
Brain death is defined as the irreversible cessation of all 
functions of the entire brain [1]. The clinical brain death 
diagnosis is based on the three brain stem criteria: total 
and irreversible coma with a known cause, the absence of 
brain stem reflexes, and apnoea [2]. However, determin-
ing these clinical criteria may be hindered by complex or 
spontaneous motor movements; false-positive triggering 
of the ventilator [1]; or particular contexts, such as barbi-
turic impregnation, hypothermia, haemodynamic insta-
bility, drug intoxication, or immature central nervous 
system in young children [3]. Thus, a brain death diagno-
sis may require confirmatory tests, which are mandatory 
in several countries. Ideally, these tests would explore the 
entire brain functions (and confirm whole brain death) 
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including supra-tentorial cortex (neocortical brain death) 
and brain stem (brain stem death). Nevertheless, most of 
them explore only cortex, notably computed tomography 
angiography (CTA) when used as actually preconized. 
This is a critical issue particularly when clinical diagnosis 
is uncertain [4, 5]. There are two types of ancillary tests. 
The first type analyses brain functions and includes EEG, 
auditory-evoked potentials, and somatosensory-evoked 
potentials. However, these tests present the same limita-
tions as clinical examinations in cases of drug impregna-
tion or hypothermia [6]. Furthermore, the tools required 
to perform and analyse cerebral functions are limited to 
the largest centres [7].
The second type of ancillary test aims to show cerebral 
circulation arrest and includes digital subtraction angiog-
raphy (DSA), computed tomography angiography (CTA) 
[8], transcranial Doppler [9], encephalic scintigraphy, and 
MR angiography [10–12].
In European countries, CTA is performed in approxi-
mately 40 % of cases that require an ancillary test because 
of either a legal requirement or the failure to perform a 
clinical diagnosis [13, 14]. Computed tomography has 
the advantages of being widely available and less invasive 
than the reference digital subtraction angiography (DSA), 
less time-consuming than MR angiography or encephalic 
scintigraphy, and less dependent on the operator than 
transcranial Doppler. Finally, CTA is the only test that 
allows for simultaneous pre-harvesting body scanning 
[15]. Few CTA scores have been proposed for diagnos-
ing brain death [8, 15], and the most recent and currently 
used consists of four criteria: the non-opacification of the 
cortical segment of each middle cerebral artery (C-MCA) 
and the non-opacification of each internal cortical vein 
(ICV), with the latter being the most sensitive [15]. How-
ever, this score suffers from an imperfect and variable 
sensitivity of 73–96 % [15–18] and is limited in the con-
text of decompressive craniectomy due to an intracra-
nial hypertension decrease [19]. Moreover, the reference 
CTA score only includes an analysis of the supratento-
rial circulation, although a clinical brain death diagnosis 
relies on infratentorial-related function arrest, which is 
assessed in clinical practice by the absence of brain stem 
reflexes.
As a consequence, we elaborated a new score to assess 
whole brain circulation stop and to increase sensitivity 
for promoting CTA as the preferred ancillary test in diag-
nosing brain death.
Thus, the aim of this study was to assess the diagnos-
tic performance of a revised four-point brain death CTA 
score that relies on the non-opacification of both the 
ICV (ever used in the precedent score) and infratentorial 
superior petrosal vein (SPV) (new criterion) compared 
with the previous reference CTA score.
Methods
Patient selection
Institutional review board approval was obtained prior to 
the study (committee’s reference number 13.61). Between 
July 1, 2011, and July 1, 2013, in a university centre, 76 
consecutive patients were examined using CTA to con-
firm cerebral circulation arrest after a clinical diagnosis 
of brain death. The clinical diagnosis of brain death was 
made by trained intensivists according to international 
guidelines [20]. As recommended, CTA was performed 
at least 6 h after clinical diagnosis and was repeated 6 h 
later if the reference CTA score did not confirm cerebral 
circulation arrest [21].
Preliminary anatomical study of infratentorial veins 
to develop a revised four‑point venous CTA score
A preliminary anatomical study aimed to assess the 
anatomical features of venous circulation, particularly 
infratentorial features, for selecting the most constantly 
visible veins to develop a new and reliable venous CTA 
score. For this, 43 control patients (11 men and 32 
women, mean age 38.6, range 17–66  years) were exam-
ined using CTA based on clinical suspicion of thrombo-
phlebitis, not confirmed by a CTA that was normal. The 
analysis classified the ICV and SPV (Fig. 1) as exhibiting 
complete visibility, visibility with hypoplasia, or lack of 
visibility [22]. The SPV is described in anatomical studies 
as one of the largest infratentorial venous stems [22, 23] 
and is of particular interest because it receives the larg-
est number of tributary veins from the brain stem: the 
pontotrigeminal, transverse pontine, cerebellopontine 
fissure, and middle cerebellar peduncle veins. The last 
portion of the SPV, formed by a single vein segment or by 
the union of several veins, drains into the superior pet-
rosal sinus. The basilar artery was not assessed because 
of a previously demonstrated low sensitivity of approxi-
mately 80–85 % [15, 16].
Fig. 1 CTA axial views (a, b) of a control patient. Arrows indicate SPV
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The ICV was easily observed and was normotrophic 
in all the patients, confirming previous studies [8]. The 
SPV, vessel that was not usually described by radiologists, 
was observed in all the patients, although it was found to 
be hypotrophic in 26 % of cases. Moreover, our findings 
confirmed published reports of varying SPV positions 
between the lateral or medial sides of the internal acous-
tic meatus [22–24]. Finally, the SPV and ICV were con-
sistently visible in the control patients.
Collection of clinical and investigative data related to brain 
death patients
Data on the following variables were collected: age, 
sex, origin of brain death, and history of decompressive 
craniectomy. The results of the apnoea test were pro-
vided. Physiological and biological parameters that may 
interfere with a diagnosis of brain death and the results 
of the CTAs were recorded at the time that CTA was 
performed. Finally, catecholamine use and dosage were 
reported.
CTA imaging
CTAs were performed using the Lightspeed multidetec-
tor GE scanner with 64 rows (GE Healthcare, Wauke-
sha, WI). We followed the recommendations of the 
French Society of Neuroradiology [21] for the CTA pro-
tocol, with an initial spiral acquisition without contrast 
medium, a second scanning spiral 20 s after the injection 
of contrast medium to assess intravenous injection, and a 
final phase 60 s after the injection to study the opacifica-
tion of the cerebral vessels.
The window centre was preset at 40 Hounsfield units 
(HU) with a width of 100 HU.
The same CTA protocol was used for the control 
patient group and the clinical brain death patients, with a 
spiral acquisition starting 60 s after intravenous medium 
contrast injection.
Image analysis
For both the patients with clinical brain death and the 
control patients, a consensus review of the CTA images 
was conducted by two trained radiologists with 10 years 
of experience. The visibility of the ICV, C-MCA, and 
infratentorial SPV was classified as opacification or 
non-opacification.
Statistical analysis
The revised four-point venous score was based on the 
non-opacification of both the ICV and SPV, with a posi-
tive score indicating complete non-opacification. Using 
the previous reference four-point CTA score [15], a 
positive score indicated that both the ICV and C-MCA 
were non-opacified. The scores for each patient were 
determined by both examining radiologists. The sensitiv-
ity of each score to determine cerebral circulation arrest 
was calculated using a clinical brain death diagnosis as 
the benchmark for analysis.
Results
Patient characteristics
The study included 76 patients, of whom 47 were male 
(62  %), with a mean age of 52 ±  16  years and a mean 
initial Glasgow coma score of 7 ± 4. The origins of brain 
death were intracranial aneurysm (n  =  25), traumatic 
brain injury (n =  24), stroke (n =  10), cerebral haem-
orrhage (n  =  9), cerebral anoxia (n  =  7) and infec-
tion (n  =  1). The results of the apnoea test showed a 
mean arterial PCO2 equal to 80 ± 19 mmHg; however, 
data were not reported in 26 patients because of oxy-
gen desaturation (n  =  20), haemodynamic instabil-
ity (n = 3), pregnancy (n = 1), or missing data (n = 2). 
Eight of the 76 included patients had decompressive 
craniectomy.
Physiological parameters recorded at the moment of 
brain death are provided in Table 1.
A second CTA was performed six hours after the first 
for seven of the 76 included patients because the first 
CTA did not confirm brain death according to the ref-
erence four-point CTA score. Finally, 83 CTAs were 
analysed including a total of ten CTAs in patients with 
decompressive craniectomy (Fig. 2).
Diagnostic performance of brain death CTA scores
The second scanning spiral realized 20 s after the injec-
tion of contrast medium assessed effective intravenous 
injection in all the cases.
The reference CTA score and the revised four-point 
venous CTA score confirmed cerebral circulation arrest 
Table 1 Physiological parameters and catecholamine used 
at the time of CT angiography (n = 76)
CTA, computed tomography angiography; PaCO2, carbon dioxide arterial 
pressure; PaO2, oxygen arterial pressure; FiO2, inspiratory oxygen fraction
a Mean ± SD [lower bound − upper bound]
b Norepinephrine, n = 67; epinephrine, n = 1; norepinephrine–dobutamine, 
n = 3; norepinephrine–epinephrine, n = 1
Body core temperature (°C) 36.8 ± 1.1 [32.8–39.9]a
Mean arterial pressure (mmHg) 80 ± 19
Natraemia (mmol/l) 147 ± 7
PaCO2 (mmHg) 37 ± 10
Haemoglobin (g/dl) 10.7 ± 2.3
PaO2/FiO2 326 ± 105
Diabetes insipidus 59 (78 %)
Catecholamine useb 72 (86 %)
Catecholamine dose (µg/kg min−1) 0.04 ± 0.06
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(positive score) with sensitivities of 88  % (73/83) and 
95 % (79/83), respectively.
Six CTAs examinations showed persistent opacification 
of the C-MCA (with negative reference CTA score) asso-
ciated with non-opacification of the SPV (Fig. 3). Different 
aetiologies were described in these six cases: two CTAs 
were performed in patients with infratentorial haemor-
rhage, one in cerebral anoxia, one in supratentorial bal-
listic injury, and two in patients with decompressive 
craniectomy. These six cases of false-negative reference 
CTA scores are described for each vessel in Table 2.
In the decompressive craniectomy group, the refer-
ence CTA score confirmed brain death in 8/10 CTAs (6/8 
patients), corresponding to a sensitivity of 80 %, whereas 
the revised four-point venous CTA score confirmed 
cerebral circulation arrest in all cases, corresponding to a 
sensitivity of 100 %.
Among the seven patients for whom a second CTA 
was needed because the first did not confirm circulatory 
arrest according to the reference CTA score, three had 
infratentorial haemorrhage, and two had decompressive 
craniectomy (Fig. 4). The revised four-point venous CTA 
score analysed with the initial CTA showed no opacifica-
tion of the ICV and SPV (positive four-point venous CTA 
score) in five of the seven patients.
Non-opacification of the SPV was observed in 95 % of 
the patients, corresponding to the high sensitivity of this 
criterion from the infratentorial circulation. The SPV was 
still opacified in four CTAs (4/83) (Table 2): two in cere-
bral anoxia, one with a diffuse cerebral haemorrhage, and 
one with an ischaemic stroke. The SPV was not opaci-
fied in any cases for which the CTA reference score con-
firmed cerebral circulation arrest. In one case, SPV was 
still opacified with a lack of ICV opacification (case of 
cerebral anoxia).
There was no case where only 1 of the 2 ICV or 1 of the 
2 SPV was opacified contrary to C-MCA (Table 2).
Fig. 2 Study’s flowchart
Fig. 3 CTA axial views of a clinically brain-dead patient with a lack 
of SPV opacification (a) despite an enhanced bilateral C-MCA (b) 
(arrows)
Table 2 CTAs with  persistent opacified vessels among   
patients with a clinical brain death diagnosis (n = 83)
Data are expressed as n. Considering ICV and SPV, there was no case where only 
one vessel side (left or right) was enhanced or not contrary to C-MCA
C-MCA cortical segment of middle cerebral artery, ICV internal cerebral vein, BA 
basilar artery, SPV superior petrosal vein
Vessel type CTA examination(s) in which 
vessel type is still opacified
2 C-MCA (left and right) 8
1 C-MCA (left or right) 10
ICV 3
BA 15
SPV 4
Fig. 4 CTA axial views of a clinically brain-dead patient with a 
craniectomy and no opacification of the SPV (a) despite persistent 
enhancement of the bilateral C-MCA (b)
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Discussion
Our revised four-point venous CTA score relies on the 
non-opacification of both the ICV and the SPV and is the 
first score to consider infratentorial circulation within a 
model of clinical diagnostic criteria. This score provides a 
high sensitivity of 95 % to confirm brain death diagnosis, 
which is higher than the previous reference CTA score. 
This new score is especially highly efficient in cases of 
decompressive craniectomy, for which it has a sensitivity 
of 100 %. In addition, the new score eliminated the need 
to perform a second CTA 6 h after the first in five out of 
seven cases and should therefore save time in confirming 
cerebral circulation arrest after the initial CTA. Moreo-
ver, the visibility of the ICV and SPV was consistent in 
healthy patients.
Brain death is a clinical diagnosis [1] that some-
times must be confirmed by ancillary tests. These tests 
must ideally prove the whole brain death. Regardless of 
whether they are optional or mandatory, these confirma-
tory tests must demonstrate high specificity and very 
high sensitivity. Moreover, an ancillary test should be as 
minimally invasive as possible, readily available, and safe 
[25]. CTA has the advantages of wide availability and 
rapid performance with low operator dependence and 
low invasivity. However, a main criticism of CTA is its 
poor sensitivity in cases of clinical brain death with per-
sistent arterial enhancement [26]; this was particularly 
applicable to early studies with a lack of reliable and rel-
evant diagnostic criteria. However, recent studies have 
determined a more sensitive diagnostic score [15], which 
has been accepted by the scientific community [21]. 
Dupas et al. were the first to describe a diagnostic score 
based on a seven-point score [8], which Frampas et  al. 
simplified to establish the current four-point reference 
score based on the lack of opacification of each ICV and 
C-MCA [15]. Frampas et al. found that the sensitivity of 
this score (85.7 %) was better than the earlier seven-point 
score (62.8 %), although a recent study showed a compa-
rable sensitivity of 73  % for both scores [17]. We found 
a comparable sensitivity of 88  % for the reference four-
point score in the present study.
Our revised four-point CTA score focused on venous 
circulation and provided a sensitivity of 95  %, which 
is higher than the reference CTA score. The relevance 
of the venous circulation to confirm circulatory arrest 
was previously reported by Frampas et  al., who showed 
that the absence of ICV opacification was more sensi-
tive than the absence of C-MCA opacification [15]. Our 
study confirmed that the absence of ICV opacification 
was the most sensitive criterion. To explain this result, 
we hypothesize that if the systemic arterial pressure 
is sufficient for arterial and superficial vein enhance-
ment, it does not go through the capillary bed and 
deep veins. Indeed, Asgeirsson et al. showed that for an 
organ enclosed in a rigid compartment, a tissue pres-
sure increase led exclusively to an increase in venous 
side resistance with no arterial resistance change [27]. In 
cases of brain death, the intracranial pressure and deep 
venous resistance would be sufficiently high to prevent 
blood or contrast medium from flowing through the ICV. 
This hypothesis is also supported by the high sensitiv-
ity of the hypoperfusion on computed tomography (CT) 
perfusion images [17]. It could be very seducing to con-
clude that no venous enhancement means no perfusion 
in CT. Nevertheless, no study had ever demonstrated this 
theory to our knowledge.
A unique feature of our revised four-point CTA score, 
beyond its focus on venous circulation, is that it consid-
ers the infratentorial circulation, unlike previous CTA 
scores, which only analysed the supratentorial circula-
tion and consequently allowing to a whole brain death 
diagnosis. However, a clinical diagnosis of brain death 
involves examination of the brain stem only, which is 
why Joffe et al. emphasized that a brain-dead patient does 
not need to have irreversible loss of the entire brain to 
be dead [28]. Indeed, it is known that several encephalic 
functions may be retained in brain-dead patients [29].
The SPV, which was shown to be consistently visible in 
healthy patients despite the presence of hypotrophy in 
26 % of cases, was selected as the primary criterion in the 
new score, in combination with the infratentorial circula-
tion and a clinical brain stem examination.
Finally, a main advantage of our revised four-point 
venous CTA score is its performance in confirming brain 
death in patients with previous decompressive craniec-
tomy. These patients were a well-known limitation of 
previous reference CTA scores because of reduced 
intracranial pressure leading to frequent arterial per-
sistent opacification [16, 30]. In our study, no cases of 
ICV or SPV opacification were recorded in patients 
with decompressive craniectomy. We hypothesized that 
the intracranial arterial pressure decrease was sufficient 
to enhance cerebral arterial trunks but not to opacify 
deep veins. This result is of great interest for such cases 
because until now, invasive conventional angiography 
was the only relevant cerebral circulation arrest confirm-
atory test [15, 19, 31, 32].
Our study had several limitations that should be noted. 
First, this study was realized with a 64-detector scanner 
and to our knowledge, no study has ever compared 64-, 32-, 
and 16- or low detector scanners in brain death diagnosis. 
Indeed, further investigations are necessary to validate our 
revised four-point venous CTA score in 32- or low detec-
tor scanners. Second, variations in the SPV may have led 
to difficulties in the analysis. Moreover, most of the radi-
ologists do not usually describe this vessel and do not know 
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where is it exactly located. Nevertheless, this limitation is 
relative if we consider that interpreting CTAs to confirm 
brain death requires the expertise of a senior radiologist 
[7]. Finally, in our study, CTA was not compared to another 
ancillary test, as EEG or else DSA (the reference exami-
nation for circulatory arrest), but DSA is an invasive and 
time-consuming test that is only available in a few reference 
centres. Moreover, few previous studies have compared 
CTA to other tests, and we consider in principle the clinical 
diagnosis of brain death as the gold standard for assessing 
the performance of an ancillary test [33].
The innovative and highly sensitive venous score we 
propose may constitute the reference ancillary test for 
diagnosing brain death. CTA is likely more relevant for 
brain death management because it allows simultaneous 
pre-harvesting body scanning, which is very important 
because it allows critical time savings during organ har-
vesting [15]. As recommended, a 6-h delay was respected 
in our study between clinical brain death diagnosis and 
CTA realization [21]. Nevertheless, it would be interest-
ing to test the sensitivity of our revised four-point venous 
CTA score when the ancillary test is realized earlier in 
order to reduce the whole-organ retrieval procedure.
Moreover, in the next few years, technological advances 
in mobile CT may increase the time savings and avoid 
haemodynamic instability due to patient transport, thus 
transforming CTA into a bedside ancillary test [34].
Conclusion
A revised four-point venous CTA score based on the 
non-opacification of both the ICV and the SPV is reliable 
for confirming cerebral circulation arrest in correlation 
with clinical brain death, with an improved diagnos-
tic performance compared with the previous reference 
CTA score. Moreover, this revised four-point CTA score 
offers higher efficiency for patients with decompressive 
craniectomy.
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